Format

Send to

Choose Destination
See comment in PubMed Commons below
Bioanalysis. 2012 Jan;4(1):71-88. doi: 10.4155/bio.11.291.

Impact of the emergence of designer drugs upon sports doping testing.

Author information

1
HFL Sport Science (an LGC Ltd. Company), Newmarket Road, Fordham, Cambridgeshire, CB7 5WW, UK. pteale@hfl.co.uk

Abstract

Historically, dope-testing methods have been developed to target specific and known threats to the integrity of sport. Traditionally, the source of new analytical targets for which testing was required were derived almost exclusively from the pharmaceutical industry. More recently, the emergence of designer drugs, such as tetrahydrogestrinone that are specifically intended to evade detection, or novel chemicals intended to circumvent laws controlling the sale and distribution of recreational drugs, such as anabolic steroids, stimulants and cannabinoids, have become a significant issue. In this review, we shall consider the emergence of designer drugs and the response of dope-testing laboratories to these new threats, in particular developments in analytical methods, instrumentation and research intended to detect their abuse, and we consider the likely future impact of these approaches.

PMID:
22191595
DOI:
10.4155/bio.11.291
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center